SE7506313L - Sett att framstella ett prostaglandinkonjugat - Google Patents

Sett att framstella ett prostaglandinkonjugat

Info

Publication number
SE7506313L
SE7506313L SE7506313A SE7506313A SE7506313L SE 7506313 L SE7506313 L SE 7506313L SE 7506313 A SE7506313 A SE 7506313A SE 7506313 A SE7506313 A SE 7506313A SE 7506313 L SE7506313 L SE 7506313L
Authority
SE
Sweden
Prior art keywords
prostagland
conjugate
country
produce
way
Prior art date
Application number
SE7506313A
Other languages
English (en)
Swedish (sv)
Inventor
S Wilkinson
R J Flower
S H Ferreira
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB24660/74A external-priority patent/GB1516642A/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SE7506313L publication Critical patent/SE7506313L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F11/00—Compounds of calcium, strontium, or barium
    • C01F11/46—Sulfates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Geology (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7506313A 1974-06-04 1975-06-03 Sett att framstella ett prostaglandinkonjugat SE7506313L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB24660/74A GB1516642A (en) 1974-06-04 1974-06-04 Biological reagent
GB5398674 1974-12-13

Publications (1)

Publication Number Publication Date
SE7506313L true SE7506313L (sv) 1975-12-05

Family

ID=26257224

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7506313A SE7506313L (sv) 1974-06-04 1975-06-03 Sett att framstella ett prostaglandinkonjugat

Country Status (12)

Country Link
US (1) US4110432A (en:Method)
JP (1) JPS519714A (en:Method)
AU (1) AU8180175A (en:Method)
CH (1) CH614221A5 (en:Method)
DE (1) DE2524637A1 (en:Method)
DK (1) DK248775A (en:Method)
ES (1) ES438163A1 (en:Method)
FI (1) FI751633A7 (en:Method)
FR (1) FR2273554A1 (en:Method)
IL (1) IL47412A0 (en:Method)
NL (1) NL7506560A (en:Method)
SE (1) SE7506313L (en:Method)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678671A (en) * 1981-12-15 1987-07-07 Cordis Europa N.V. Conjugates of anticoagulant and protein
NL188622C (nl) * 1981-12-15 1992-08-17 Cordis Europ Werkwijze ter verbetering van de bloedcompatibiliteit van een materiaaloppervlak door bekleding daarvan met een heparine of heparine-analoga en een eiwit houdende film, alsmede voorwerp, omvattende een oppervlak met verbeterde bloedcompatibiliteit verkregen onder toepassing van een op het oppervlak aangebrachte heparine of heparine-analoga en een eiwit houdende film.
US4749570A (en) * 1981-12-31 1988-06-07 The Governors Of The University Of Alberta Targeting conjugates of albumin and therapeutic agents
US4663160A (en) * 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
EP0172962A1 (en) * 1984-08-30 1986-03-05 Ono Pharmaceutical Co., Ltd. Prostaglandins
DE68919366T2 (de) * 1988-09-30 1995-05-18 Neorx Corp Spaltbare linker zur reduzierung der akkumulierung von immunokonjugaten in nicht-zielorganen.
US5171563A (en) * 1988-09-30 1992-12-15 Neorx Corporation Cleavable linkers for the reduction of non-target organ retention of immunoconjugates
US6007817A (en) 1988-10-11 1999-12-28 University Of Southern California Vasopermeability enhancing immunoconjugates
EP0540670B1 (en) * 1990-07-26 1996-03-20 Monsanto Company Method for preparation of crosslinked polyamines
US8333996B2 (en) * 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
US8728536B2 (en) * 1996-10-16 2014-05-20 Etex Corporation Chemotherapeutic composition using nanocrystalline calcium phosphate paste
EP3254710B1 (en) * 2003-04-11 2019-05-22 Etex Corporation Osteoinductive bone material
KR101218454B1 (ko) * 2004-04-15 2013-01-04 에텍스 코포레이션 세팅 지연 칼슘 포스페이트 페이스트
US8147860B2 (en) 2005-12-06 2012-04-03 Etex Corporation Porous calcium phosphate bone material

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3690834A (en) * 1971-01-11 1972-09-12 Syva Co Ligand determination with spin labeled compounds by receptor displacement
US3935074A (en) * 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies

Also Published As

Publication number Publication date
NL7506560A (nl) 1975-12-08
US4110432A (en) 1978-08-29
FI751633A7 (en:Method) 1975-12-05
DE2524637A1 (de) 1976-01-02
DK248775A (da) 1975-12-05
IL47412A0 (en) 1975-08-31
CH614221A5 (en:Method) 1979-11-15
FR2273554B1 (en:Method) 1978-07-28
ES438163A1 (es) 1977-05-16
AU8180175A (en) 1976-12-09
JPS519714A (en:Method) 1976-01-26
FR2273554A1 (fr) 1976-01-02

Similar Documents

Publication Publication Date Title
SE420405B (sv) Sett att framstella ett polykarboxylatcement
SE7500604L (sv) Sett att legesfixera ett fartyg
SE405735B (sv) Sett att framstella ett mikroporost membran
SE7512087L (sv) Sett att framstella vattensvellbar polyalkylenoxid
IT1042001B (it) Miglioramenti relativi a laminati
IT1042000B (it) Miglioramenti relativi a laminati
SE7505189L (sv) Sett att forbettra segheten hos ett format foremal.
SE7614587L (sv) Sett att igangsetta ett forbrenningssystem
SE7506313L (sv) Sett att framstella ett prostaglandinkonjugat
SE7506687L (sv) Sett att framstella aminotetralolforeningar.
IT1031876B (it) Perfezionamenti relative a meccanismi di trasmissione
SE7805290L (sv) Sett att tillverka ett metallhaltigt foremal
SE425453B (sv) Sett att framstella ett konditorifett
SE381251B (sv) Sett att framstella en kontaktkropp
SE418155B (sv) Sett att framstella ett oljeabsorberande material
SE7509145L (sv) Sett att framstella ett djupdragninsmedel.
SE418466B (sv) Sett att framstella ett stalgjutstycke
SE7608262L (sv) Sett att framstella en katalysator
SE400202B (sv) Sett att framstella en svetselektrod
SE418294B (sv) Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester
SE408837B (sv) Sett att framstella ett termoelement
SE7612723L (sv) Sett att framstella ett forband
SE405525B (sv) Sett att framstella ett halvledaraggregat
SE7709507L (sv) Sett att framstella en behensyraester
SE7509513L (sv) Sett att framstella bietamidderivat